160 related articles for article (PubMed ID: 7703623)
1. Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis.
Rizzoli R; Chevalley T; Slosman DO; Bonjour JP
Osteoporos Int; 1995 Jan; 5(1):39-46. PubMed ID: 7703623
[TBL] [Abstract][Full Text] [Related]
2. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Struys A; Snelder AA; Mulder H
Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
[TBL] [Abstract][Full Text] [Related]
3. Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
Reginster JY; Felsenberg D; Pavo I; Stepan J; Payer J; Resch H; Glüer CC; Mühlenbacher D; Quail D; Schmitt H; Nickelsen T
Osteoporos Int; 2003 Sep; 14(9):741-9. PubMed ID: 12827224
[TBL] [Abstract][Full Text] [Related]
4. Fluoride pharmacokinetics and changes in lumbar spine and hip bone mineral density.
Patel S; Chan JK; Hosking DJ
Bone; 1996 Dec; 19(6):651-5. PubMed ID: 8968033
[TBL] [Abstract][Full Text] [Related]
5. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
Reginster JY; Meurmans L; Zegels B; Rovati LC; Minne HW; Giacovelli G; Taquet AN; Setnikar I; Collette J; Gosset C
Ann Intern Med; 1998 Jul; 129(1):1-8. PubMed ID: 9652994
[TBL] [Abstract][Full Text] [Related]
6. In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study.
Guaydier-Souquières G; Kotzki PO; Sabatier JP; Basse-Cathalinat B; Loeb G
Osteoporos Int; 1996; 6(2):171-7. PubMed ID: 8704358
[TBL] [Abstract][Full Text] [Related]
7. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.
Meys E; Terreaux-Duvert F; Beaume-Six T; Dureau G; Meunier PJ
Osteoporos Int; 1993 Dec; 3(6):322-9. PubMed ID: 8292843
[TBL] [Abstract][Full Text] [Related]
8. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
[TBL] [Abstract][Full Text] [Related]
9. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
Ringe JD; Kipshoven C; Cöster A; Umbach R
Osteoporos Int; 1999; 9(2):171-8. PubMed ID: 10367046
[TBL] [Abstract][Full Text] [Related]
10. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
Alexandersen P; Riis BJ; Christiansen C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S;
Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500
[TBL] [Abstract][Full Text] [Related]
12. Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study.
Sebert JL; Richard P; Mennecier I; Bisset JP; Loeb G
Osteoporos Int; 1995 Mar; 5(2):108-14. PubMed ID: 7599447
[TBL] [Abstract][Full Text] [Related]
13. Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site.
Resch H; Libanati C; Farley S; Bettica P; Schulz E; Baylink DJ
J Clin Endocrinol Metab; 1993 Jun; 76(6):1622-4. PubMed ID: 8501171
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid effects on proximal femur bone loss.
Sambrook P; Birmingham J; Kempler S; Kelly P; Eberl S; Pocock N; Yeates M; Eisman J
J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
[TBL] [Abstract][Full Text] [Related]
15. Monofluorophosphate combined with hormone replacement therapy in postmenopausal osteoporosis. An open-label pilot efficacy and safety study.
Ringe JD; Setnikar I
Rheumatol Int; 2002 May; 22(1):27-32. PubMed ID: 12120908
[TBL] [Abstract][Full Text] [Related]
16. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
Reid IR; Cundy T; Grey AB; Horne A; Clearwater J; Ames R; Orr-Walker BJ; Wu F; Evans MC; Gamble GD; King A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2446-52. PubMed ID: 17440020
[TBL] [Abstract][Full Text] [Related]
17. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate.
Ringe JD; Dorst A; Kipshoven C; Rovati LC; Setnikar I
Osteoporos Int; 1998; 8(1):47-52. PubMed ID: 9692077
[TBL] [Abstract][Full Text] [Related]
18. Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study.
Lippuner K; Haller B; Casez JP; Montandon A; Jaeger P
Miner Electrolyte Metab; 1996; 22(4):207-13. PubMed ID: 8807623
[TBL] [Abstract][Full Text] [Related]
19. Long-term corticosteroid therapy induces mild changes in trabecular bone texture.
Lespessailles E; Siroux V; Poupon S; Andriambelosoa N; Pothuaud L; Harba R; Benhamou CL
J Bone Miner Res; 2000 Apr; 15(4):747-53. PubMed ID: 10780866
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
Roux C; Oriente P; Laan R; Hughes RA; Ittner J; Goemaere S; Di Munno O; Pouillès JM; Horlait S; Cortet B
J Clin Endocrinol Metab; 1998 Apr; 83(4):1128-33. PubMed ID: 9543129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
